Research Article

A Chemiluminescent Immunoassay for Osteocalcin in Human Serum and a Solution to the “Hook Effect”

Figure 6

Distribution of clinical samples from postmenopausal women. (a) BGP <10 ng/mL. (b) BGP within 10–30 ng/mL. (c) BGP >30 ng/mL.
(a)
(b)
(c)